Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.
 |
Fac Notes. 1998 Nov-Dec;10(6):6. Unique Identifier : AIDSLINE AIDS/20700003
Abstract: The Louisiana Community AIDS Research Program (LaCARP) is conducting a Protease Inhibitor Progression (PIP) study to determine how to lower the amount of HIV virus in the body. The trial is for HIV-positive patients, over 13 years of age, who have detectable viral loads, and who are on their initial course of protease inhibitor therapy. Treatment regimens and study criteria are outlined. Contact information is provided.
000330
A0030946
Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .